Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced findings from a new U.S. healthcare database analysis to assess the current treatment patterns of adults living ...

Symptoms of spasticity — including chronic muscle stiffness, pain, and jerkiness of voluntary movements — can interfere with your daily activities. Left untreated, these symptoms may significantly ...

Animal or in vitro studies, studies performed in pediatric populations, and studies reporting treatment with BoNT products other than onabotulinumtoxinA were excluded. The full-text publications of ...